← The Wire
LXRXNasdaq
LEXICON PHARMACEUTICALS, INC.
Pharmaceutical Preparations · DE · CIK 1062822
Pioneering medicines that transform patients' lives through research, development, and commercialization of drug candidates
$853M
Market cap
$2.64
Last close
+3.5%
1D
+22.8%
5D
4.6M
Volume
Price · last 39 sessions+65.0%
May 4L $1.60 · H $2.64Jun 29
307
Total filings
May 7, 2026
Last filing
12/31
Fiscal year end
SC 13D/ASC 13D/AMay 8, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 20268-KMaterial Agreement · New Debt / ObligationMay 6, 20268-KMaterial Agreement · Equity IssuanceApr 30, 2026DEFA14ADEF 14AMar 16, 2026DEF 14ADEF 14AMar 16, 202610-K10-KMar 5, 20268-KResults of OperationsMar 5, 20268-KMaterial Agreement · Equity IssuanceFeb 2, 2026424B5424B5Feb 2, 2026SC 13D/ASC 13D/AFeb 2, 20268-KResults of Operations · Reg FD DisclosureJan 29, 2026424B5424B5Jan 29, 20268-KCompany UpdateNov 10, 2025424B5424B5Nov 6, 20258-KCompany UpdateNov 6, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KCompany UpdateJul 28, 20258-KCompany UpdateJul 3, 20258-KMaterial Agreement · Shareholder VoteJun 3, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 13, 2025DEFA14ADEFA14AApr 22, 2025DEF 14ADEF 14AApr 22, 20258-KMaterial AgreementMar 28, 202510-K10-KMar 7, 20258-KResults of OperationsMar 6, 20258-KDelisting NoticeJan 7, 20258-KExecutive ChangeJan 2, 20258-KExit / Disposal CostsNov 22, 20248-KExecutive ChangeNov 20, 202410-Q10-QNov 13, 20248-KResults of OperationsNov 12, 20248-KMaterial AgreementOct 16, 20248-KExecutive ChangeSep 16, 202410-Q10-QAug 2, 20248-KResults of OperationsAug 1, 2024SC 13GSC 13GJul 10, 20248-KExecutive ChangeJul 8, 20248-KMaterial AgreementJul 1, 20248-KEquity Issuance · Bylaw AmendmentMay 10, 202410-Q10-QMay 2, 20248-KResults of OperationsMay 2, 20248-KExecutive ChangeApr 29, 2024DEFA14ADEFA14AMar 26, 2024DEF 14ADEF 14AMar 26, 202410-K10-KMar 25, 20248-KSecurity-Holder Rights · Bylaw AmendmentMar 12, 20248-KMaterial Agreement · Results of OperationsMar 11, 20248-KMaterial AgreementDec 29, 2023424B5424B5Dec 29, 20238-KMaterial AgreementDec 29, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 8, 20238-KExecutive ChangeOct 11, 202310-Q10-QAug 4, 20238-KResults of OperationsAug 3, 20238-KExecutive ChangeJul 31, 20238-KExecutive ChangeJul 24, 20238-KNew Debt / Obligation · Equity IssuanceJun 28, 20238-KMaterial Agreement · Equity IssuanceJun 2, 2023424B5424B5Jun 2, 20238-KReg FD Disclosure · Company UpdateMay 31, 2023424B5424B5May 31, 20238-K/AShareholder VoteMay 8, 202310-Q10-QMay 4, 20238-KMaterial AgreementMay 2, 20238-KResults of OperationsMay 2, 20238-KMaterial Agreement · Shareholder VoteApr 27, 2023DEFA14ADEFA14AMar 17, 2023DEF 14ADEF 14AMar 17, 202310-K10-KMar 3, 20238-KResults of OperationsMar 2, 20238-KNew Debt / Obligation · Equity IssuanceJan 4, 202310-Q10-QNov 9, 20228-KResults of OperationsNov 9, 2022
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Feb 25, 2026: 2 insiders bought $2.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 25, 2026 | Debbane RaymondDirector | Buy | 2,000 | $1.49 | $3K |
| Feb 23, 2026 | Debbane RaymondDirector | Buy | 100,000 | $1.47 | $147K |
| Feb 20, 2026 | Debbane RaymondDirector | Buy | 100,000 | $1.48 | $148K |
| Feb 19, 2026 | Debbane RaymondDirector | Buy | 50,000 | $1.44 | $72K |
| Feb 18, 2026 | Debbane RaymondDirector | Buy | 133,688 | $1.32 | $176K |
| Feb 17, 2026 | Debbane RaymondDirector | Buy | 76,857 | $1.31 | $101K |
| Feb 13, 2026 | Debbane RaymondDirector | Buy | 57,952 | $1.31 | $76K |
| Feb 2, 2026 | Artal Group S.A.Director,TenPercentOwner | Buy | 1,538,462 | $1.30 | $2.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance